Amylyx Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Amylyx Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Amylyx Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Amylyx Pharmaceuticals by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $574k | 39k | 14.72 |
| 2023-09-30 | $84k | 4.6k | 18.31 |
| 2023-06-30 | $2.2M | 102k | 21.57 |
| 2023-03-31 | $3.8M | 130k | 29.34 |
| 2022-12-31 | $1.2M | 31k | 36.95 |
| 2022-09-30 | $3.8M | 134k | 28.00 |
| 2022-06-30 | $3.0k | 177 | 16.95 |
| 2022-03-31 | $53k | 4.2k | 12.75 |